Development and validation of an m6A and autophagy related lncRNAs signature for predicting survival and modulating the immune microenvironment in esophageal squamous cell carcinoma - Top-Institutions - MDSpire

Development and validation of an m6A and autophagy related lncRNAs signature for predicting survival and modulating the immune microenvironment in esophageal squamous cell carcinoma

  • By

  • Mingyi Yang

  • Honghao Ren

  • Jing Hu

  • Pengfei Wen

  • Jiale Xie

  • Xianjie Wan

  • Lin Liu

  • Zhi Yang

  • Ming Zhang

  • Xiaodong Ren

  • Yani Su

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS)
    National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS)

    Beijing, China

    Key Differentiators

    • Oncology
    • Cancer Research

  • #2

    Sun Yat-sen University Cancer Center (SYSUCC)
    Sun Yat-sen University Cancer Center (SYSUCC)

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology
    • Cancer Research

Original Source(s)

Development and validation of an m6A and autophagy related lncRNAs signature for predicting survival and modulating the immune microenvironment in esophageal squamous cell carcinoma

  • by Mingyi Yang, Honghao Ren, Jing Hu, Pengfei Wen, Jiale Xie, Xianjie Wan, Lin Liu, Zhi Yang, Ming Zhang, Xiaodong Ren, Yani Su

  • May 28, 2026

Related Content

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Primary central nervous system lymphoma and tumefactive demyelinating lesions in multiple sclerosis: a retrospective observational cohort study

High-grade astrocytoma with piloid features: a case report of comprehensive management